deltatrials
Completed PHASE1 INTERVENTIONAL 3-arm NCT02391480

A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer

A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Advanced Cancer

Sponsor: AbbVie

Conditions Acute Myeloid Leukemia (AML) Breast Cancer Cancer Multiple Myeloma Non-Hodgkins Lymphoma Non-Small Cell Lung Cancer Prostate Cancer Small Cell Lung Cancer
Interventions ABBV-075 Venetoclax
Updated 15 times since 2017 Last updated: Nov 27, 2019 Started: Apr 14, 2015 Primary completion: Jul 5, 2019 Completion: Jul 5, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Acute Myeloid Leukemia (AML) and Breast Cancer and is currently completed. AbbVie leads this study, which shows 15 recorded versions since 2015 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Apr 2017 · 59 days · monthly snapshot~Apr 2017 – ~Jun 2017 · 2 months · monthly snapshot~Jun 2017 – ~Mar 2018 · 9 months · monthly snapshot~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Jan 2019 · 5 months · monthly snapshot~Jan 2019 – ~Mar 2019 · 59 days · monthly snapshot~Mar 2019 – ~Aug 2019 · 5 months · monthly snapshot~Aug 2019 – ~Dec 2019 · 4 months · monthly snapshot~Dec 2019 – ~Jan 2021 · 13 months · monthly snapshot~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 23 months · monthly snapshot

Change History

15 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Dec 2019 — Jan 2021 [monthly]

    Completed PHASE1

  5. Aug 2019 — Dec 2019 [monthly]

    Completed PHASE1

    Status: Active Not Recruiting → Completed

▶ Show 10 earlier versions

  1. Mar 2019 — Aug 2019 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  2. Jan 2019 — Mar 2019 [monthly]

    Recruiting PHASE1

  3. Aug 2018 — Jan 2019 [monthly]

    Recruiting PHASE1

  4. Jul 2018 — Aug 2018 [monthly]

    Recruiting PHASE1

  5. Jun 2018 — Jul 2018 [monthly]

    Recruiting PHASE1

  6. Mar 2018 — Jun 2018 [monthly]

    Recruiting PHASE1

  7. Jun 2017 — Mar 2018 [monthly]

    Recruiting PHASE1

  8. Apr 2017 — Jun 2017 [monthly]

    Recruiting PHASE1

  9. Feb 2017 — Apr 2017 [monthly]

    Recruiting PHASE1

  10. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE1

    First recorded

Apr 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AbbVie
Data source: AbbVie

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations